Quality of life is decreased in female patients treated for microprolactinoma

European Journal of Endocrinology

Volumn 157, Issue 2, 2007, Pages 133-139

  Kars, M ^a   van der Klaaw, A A ^a   Onstein, C S ^a   Pereira, A M ^a   Romijn, J A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; QUINAGOLIDE;

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; FUNCTIONAL HEALTH PATTERNS; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; NOTTINGHAM EXTENDED ACTIVITIES OF DAILY LIVING SCALE; PRIORITY JOURNAL; PROLACTINOMA; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCTIVE HEALTH; ROLE CHANGE; SCORING SYSTEM; SHORT FORM 36; SOCIAL INTERACTION; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; ANXIETY; DEPRESSION; DOPAMINE AGONISTS; FATIGUE; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34547772585     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0259     Document Type: Article

References (30)

1. Ciccarelli A, Daly AF & Beckers A. The epidemiology of prolactinomas. Pituitary 2005 8 3-6.
2. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA & Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Uege, Belgium. Journal of Clinical Endocrinology and Metabolism 2006 91 4769-4775.
3. Colao A & Lombardi G. Growth-hormone and prolactin excess. Lancet 1998 352 1455-1461.
4. Gillam MP, Molitch ME, Lombardi G & Colac, A. Advances in the treatment of prolactinomas. Endocrine Reviews 2006 27 485-534.
5. Biswas M, Smith J, Jadon D, McEwan P, Rees DA, Evans LM, Scanlon MF & Davies JS. Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clinical Endocrinology 2005 63 26-31.
6. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R & Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. New England Journal of Medicine 2003 349 2023-2033.
7. Johnson MD, Woodburn CJ & Vance ML. Quality of life in patients with a pituitary adenoma. Pituitary 2003 6 81-87.
8. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA & Roelfsema F. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. Journal of Clinical Endocrinology and Metabolism 2004 89 5369-5376.
9. Van Aken MO, Pereira AM, Biernasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW & Romijn JA. Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2005 90 3279-3286.
10. Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW & Romijn JA. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism 2006 91 3364-3369.
11. Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A & Stenman UH. Quality of life in treated patients with acromegaly Journal of Clinical Endocrinology and Metabolism 2006 91 3891-3896.
12. Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM & Trainer PJ. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. Journal of Clinical Endocrinology and Metabolism 2005 90 3337-3341.
13. Lindsay JR, Nansel T, Baid S, Gumowski J & Nieman LK. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. Journal of Clinical Endocrinology and Metabolism 2006 91 447-453.
14. Sonino N, Bonnini S, Fallo F, Boscaro M & Fava GA. Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clinical Endocrinology 2006 64 314-318.
15. Romijn JA, Smit JW & Lamberts SW intrinsic imperfections of endocrine replacement therapy. European Journal of Endocrinology 2003 149 91-97.
16. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA & Pereira AM. Quality of life in treated adult craniopharyngioma patients. European Journal of Endocrinology 2006 154 483-489.
17. Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bax JJ, Romijn JA & Smit JW. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clinical Endocrinology 2006 64 284-291.
18. Ware JE, Jr & Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992 30 473-483.
19. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T & Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992 305 160-164.
20. Van der Zee KI & Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36, een handleiding Noordelijk Centrum Voor Gezondheidsvraagstukken, pp 1-28. Groningen, The Netherlands: Rijks Universiteit Groningen, 1992.
21. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J & Papp E. A quantitative approach to perceived health status: a validation study. Journal of Epidemiology and Community Health 1980 34 281-286.
22. Hunt SM & McEwen J. The development of a subjective health indicator. Sociology of Health and Illness 1980 2 231-246.
23. Smets EM, Garssen B, Bonke B & De Haes JC. The multi-dimensional fatigue inventory (WI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 1995 39 315-325.
24. Zigmond AS & Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983 67 361-370.
25. McMillan CV, Bradley C, Gibney J, Russell-Jones DL & Sonksen PH. Evaluation of two health status measures in adults with growth hormone deficiency. Clinical Endocrinology 2003 58 436-445.
26. Webb SM, Prieto L, Badia. X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo, C, Pico A, Lucas A, Halperin I, Obiols G & Astorga R. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clinical Endocrinology 2002 57 251-258.
27. Nicholas L, Dawkins K & Golden RN. Psychoneuroendocrinology of depression. Prolactin. Psychiatric Clinics of North America 1998 21 341-358.
28. Sobrinho LG. Emotional aspects of hyperprolactinemia. Psychotherapy and Psychosomatics 1998 67 133-139.
29. Zhang A, Neumeyer JL & Baldessarini R.J. Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chemical Reviews 2007 107 274-302.
30. Jackson JL, Kroenke K & Chamberlin J. Effects of physician awareness of symptom-related expectations and mental disorders. A controlled trial. Archives of Family Medicine 1999 8 135-142.